Editorial: risk factors for persistent villus atrophy in coeliac disease - is it time to reconsider definitions for refractory coeliac disease? Authors' reply

Affiliations

¹ Celiac Disease Center, Columbia University College of Physicians and Surgeons, New York, NY, USA.
² Division of Gastroenterology and Hepatology, The Mayo Clinic, Rochester, MN, USA.
³ Division of Allergy/Immunology, Department of Medicine, University of California, San Francisco, CA, USA.

Editorial

S Mahadev et al. Aliment Pharmacol Ther. 2017 Jun.

. 2017 Jun;45(11):1478-1479.

doi: 10.1111/apt.14086.

¹ Celiac Disease Center, Columbia University College of Physicians and Surgeons, New York, NY, USA.
² Division of Gastroenterology and Hepatology, The Mayo Clinic, Rochester, MN, USA.
³ Division of Allergy/Immunology, Department of Medicine, University of California, San Francisco, CA, USA.

No abstract available

Comment on

Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet.
Mahadev S, Murray JA, Wu TT, Chandan VS, Torbenson MS, Kelly CP, Maki M, Green PH, Adelman D, Lebwohl B. Mahadev S, et al. Aliment Pharmacol Ther. 2017 Apr;45(8):1084-1093. doi: 10.1111/apt.13988. Epub 2017 Feb 20. Aliment Pharmacol Ther. 2017. PMID: 28220520 Clinical Trial.
Editorial: risk factors for persistent villus atrophy in coeliac disease - is it time to reconsider definitions for refractory coeliac disease?
Braude MRH, Newnham ED. Braude MRH, et al. Aliment Pharmacol Ther. 2017 Jun;45(11):1477-1478. doi: 10.1111/apt.14055. Aliment Pharmacol Ther. 2017. PMID: 28474827 No abstract available.